Tonix Pharmaceuticals (TNXP) Investor presentation - Slideshow
Tonix Pharmaceuticals (TNXP)2023-03-29 15:42© 2023 Tonix Pharmaceuticals Holding Corp. © 2023 Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is committed to improving population health by inventing and developing innovative therapies and vaccines, through broad in-house capabilities and creative collaborations, to help address important unmet needs. Investment Highlights IN-HOUSE CAPABILITIES FINANCIAL POSITION Candidates* Indication Status/Next Milestone TNX-13003 Cocaine Intoxication - FDA Breakthrough Designation Mid-Phase 2, Targeted 2 ...